Dr. Bryan J. Pace, DO

Dr. Pace practices at University Hospitals Portage Medical Center in Ravenna, Ohio, part of University Hospitals Health System.

Dr. Pace's NPI, 1023250396, was assigned on April 1, 2009. Dr. Pace holds North Carolina license 2018-00084.

Dr. Pace's primary practice is University Hospitals Portage Medical Center, at 6847 N Chestnut, Ravenna, OH 44266 in Portage County. The practice phone is (330) 297-2300.

Dr. Pace's primary practice is University Hospitals Portage Medical Center in Ravenna, Ohio, part of University Hospitals Health System. Dr. Pace is also affiliated with Cleveland Clinic Main Campus. The medical group on file is University Eyecare. Dmand AI also links Dr. Pace to 3 more hospitals, 1 group practice or clinic, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pace practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Pace's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Pace's licenses on file in 3 states: North Carolina, Michigan and Ohio.

CMS data shows 2,406 Medicare services from Dr. Pace across 21 procedure codes in 2024, for 1,015 Medicare patients. Medicare paid $84,517 for them.

CMS counts 1,015 Medicare patients who saw Dr. Pace in 2024. The largest group is 65 to 74, with 404 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pace's median patient age at 73, with 48% women.

In 2024, Dr. Pace wrote 2,923 Medicare Part D claims for 672 patients. 78% of them were for generic drugs. CMS names the drug for 2,765 of them, across 31 drugs with 11 or more claims each, at $671,309 in total drug cost. In 2023, CMS named 5,753 claims across 51 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Pace for performance year 2024, reported through an alternative payment model (APM). Dr. Pace accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Pace from 3 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 86% of the total. Abbott Laboratories paid the most, $47.